Personalized Medicine (PM) Market Revenue Drivers, Growth Opportunities, Value Chain Analysis and Forecast Research Report Till 2022
“The global personalized medicine market is expected to cross USD 2452.50 billion by 2022 with a rise in CAGR of 11.8%.”
The global Personalized Medicine (PM) Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: The global personalized medicine market is expected to cross USD 2452.50 billion by 2022 with a rise in CAGR of 11.8%. Personalized medicine is a branch of medical science encompassing the unique attributes of patients, particularly the genetic design, previous treatment history, behavioural attributes and environmental factors. It enables therapeutic and preventions for emphasizing the most beneficial treatment with low side effects. Key Players:
GE Healthcare Illumina Incorporated Asuragen Incorporated Cepheid Abbott Laboratories Dako A/S Exact Science Corporation Biogen Decode Genetics Inc. Exagen Diagnostics Inc. Genelex Corporation Precision Biologics Incorporated